Nonalcoholic Steatohepatitis (NASH) Market - Global Outlook and Forecast 2021-2027

Code: RW00014594699
Market Monitor Global
Nov-2021
Life Sciences
90 Pages

This report contains market size and forecasts of Nonalcoholic Steatohepatitis (NASH) in Global, including the following market information:
Global Nonalcoholic Steatohepatitis (NASH) Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Nonalcoholic Steatohepatitis (NASH) market was valued at 3152.9 million in 2020 and is projected to reach US$ 13820 million by 2027, at a CAGR of 44.7% during the forecast period.
Publisher has surveyed the Nonalcoholic Steatohepatitis (NASH) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nonalcoholic Steatohepatitis (NASH) Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Nonalcoholic Steatohepatitis (NASH) Market Segment Percentages, By Type, 2020 (%)
Obeticholic acid (OCA)
Selonsertib

China Nonalcoholic Steatohepatitis (NASH) Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Nonalcoholic Steatohepatitis (NASH) Market Segment Percentages, By Application, 2020 (%)
Hospital Pharmacy
Online Provider
Retail Pharmacy

Global Nonalcoholic Steatohepatitis (NASH) Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Nonalcoholic Steatohepatitis (NASH) Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Nonalcoholic Steatohepatitis (NASH) Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Nonalcoholic Steatohepatitis (NASH) Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
AstraZeneca
Arena Pharmaceuticals
GSK
Novo Nordisk
Roche
Vivus
Arisaph Pharmaceuticals
Cempra Pharmaceuticals
Galectin Therapeutics
Galmed Pharmaceuticals
Genfit
Gilead

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Nonalcoholic Steatohepatitis (NASH) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Nonalcoholic Steatohepatitis (NASH) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Nonalcoholic Steatohepatitis (NASH) Overall Market Size
2.1 Global Nonalcoholic Steatohepatitis (NASH) Market Size: 2021 VS 2027
2.2 Global Nonalcoholic Steatohepatitis (NASH) Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Nonalcoholic Steatohepatitis (NASH) Players in Global Market
3.2 Top Global Nonalcoholic Steatohepatitis (NASH) Companies Ranked by Revenue
3.3 Global Nonalcoholic Steatohepatitis (NASH) Revenue by Companies
3.4 Top 3 and Top 5 Nonalcoholic Steatohepatitis (NASH) Companies in Global Market, by Revenue in 2020
3.5 Global Companies Nonalcoholic Steatohepatitis (NASH) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Nonalcoholic Steatohepatitis (NASH) Players in Global Market
3.6.1 List of Global Tier 1 Nonalcoholic Steatohepatitis (NASH) Companies
3.6.2 List of Global Tier 2 and Tier 3 Nonalcoholic Steatohepatitis (NASH) Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Nonalcoholic Steatohepatitis (NASH) Market Size Markets, 2021 & 2027
4.1.2 Obeticholic acid (OCA)
4.1.3 Selonsertib
4.2 By Type - Global Nonalcoholic Steatohepatitis (NASH) Revenue & Forecasts
4.2.1 By Type - Global Nonalcoholic Steatohepatitis (NASH) Revenue, 2016-2021
4.2.2 By Type - Global Nonalcoholic Steatohepatitis (NASH) Revenue, 2022-2027
4.2.3 By Type - Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Nonalcoholic Steatohepatitis (NASH) Market Size, 2021 & 2027
5.1.2 Hospital Pharmacy
5.1.3 Online Provider
5.1.4 Retail Pharmacy
5.2 By Application - Global Nonalcoholic Steatohepatitis (NASH) Revenue & Forecasts
5.2.1 By Application - Global Nonalcoholic Steatohepatitis (NASH) Revenue, 2016-2021
5.2.2 By Application - Global Nonalcoholic Steatohepatitis (NASH) Revenue, 2022-2027
5.2.3 By Application - Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Nonalcoholic Steatohepatitis (NASH) Market Size, 2021 & 2027
6.2 By Region - Global Nonalcoholic Steatohepatitis (NASH) Revenue & Forecasts
6.2.1 By Region - Global Nonalcoholic Steatohepatitis (NASH) Revenue, 2016-2021
6.2.2 By Region - Global Nonalcoholic Steatohepatitis (NASH) Revenue, 2022-2027
6.2.3 By Region - Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Nonalcoholic Steatohepatitis (NASH) Revenue, 2016-2027
6.3.2 US Nonalcoholic Steatohepatitis (NASH) Market Size, 2016-2027
6.3.3 Canada Nonalcoholic Steatohepatitis (NASH) Market Size, 2016-2027
6.3.4 Mexico Nonalcoholic Steatohepatitis (NASH) Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Nonalcoholic Steatohepatitis (NASH) Revenue, 2016-2027
6.4.2 Germany Nonalcoholic Steatohepatitis (NASH) Market Size, 2016-2027
6.4.3 France Nonalcoholic Steatohepatitis (NASH) Market Size, 2016-2027
6.4.4 U.K. Nonalcoholic Steatohepatitis (NASH) Market Size, 2016-2027
6.4.5 Italy Nonalcoholic Steatohepatitis (NASH) Market Size, 2016-2027
6.4.6 Russia Nonalcoholic Steatohepatitis (NASH) Market Size, 2016-2027
6.4.7 Nordic Countries Nonalcoholic Steatohepatitis (NASH) Market Size, 2016-2027
6.4.8 Benelux Nonalcoholic Steatohepatitis (NASH) Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Nonalcoholic Steatohepatitis (NASH) Revenue, 2016-2027
6.5.2 China Nonalcoholic Steatohepatitis (NASH) Market Size, 2016-2027
6.5.3 Japan Nonalcoholic Steatohepatitis (NASH) Market Size, 2016-2027
6.5.4 South Korea Nonalcoholic Steatohepatitis (NASH) Market Size, 2016-2027
6.5.5 Southeast Asia Nonalcoholic Steatohepatitis (NASH) Market Size, 2016-2027
6.5.6 India Nonalcoholic Steatohepatitis (NASH) Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Nonalcoholic Steatohepatitis (NASH) Revenue, 2016-2027
6.6.2 Brazil Nonalcoholic Steatohepatitis (NASH) Market Size, 2016-2027
6.6.3 Argentina Nonalcoholic Steatohepatitis (NASH) Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Revenue, 2016-2027
6.7.2 Turkey Nonalcoholic Steatohepatitis (NASH) Market Size, 2016-2027
6.7.3 Israel Nonalcoholic Steatohepatitis (NASH) Market Size, 2016-2027
6.7.4 Saudi Arabia Nonalcoholic Steatohepatitis (NASH) Market Size, 2016-2027
6.7.5 UAE Nonalcoholic Steatohepatitis (NASH) Market Size, 2016-2027
7 Players Profiles
7.1 AstraZeneca
7.1.1 AstraZeneca Corporate Summary
7.1.2 AstraZeneca Business Overview
7.1.3 AstraZeneca Nonalcoholic Steatohepatitis (NASH) Major Product Offerings
7.1.4 AstraZeneca Nonalcoholic Steatohepatitis (NASH) Revenue in Global (2016-2021)
7.1.5 AstraZeneca Key News
7.2 Arena Pharmaceuticals
7.2.1 Arena Pharmaceuticals Corporate Summary
7.2.2 Arena Pharmaceuticals Business Overview
7.2.3 Arena Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Major Product Offerings
7.2.4 Arena Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue in Global (2016-2021)
7.2.5 Arena Pharmaceuticals Key News
7.3 GSK
7.3.1 GSK Corporate Summary
7.3.2 GSK Business Overview
7.3.3 GSK Nonalcoholic Steatohepatitis (NASH) Major Product Offerings
7.3.4 GSK Nonalcoholic Steatohepatitis (NASH) Revenue in Global (2016-2021)
7.3.5 GSK Key News
7.4 Novo Nordisk
7.4.1 Novo Nordisk Corporate Summary
7.4.2 Novo Nordisk Business Overview
7.4.3 Novo Nordisk Nonalcoholic Steatohepatitis (NASH) Major Product Offerings
7.4.4 Novo Nordisk Nonalcoholic Steatohepatitis (NASH) Revenue in Global (2016-2021)
7.4.5 Novo Nordisk Key News
7.5 Roche
7.5.1 Roche Corporate Summary
7.5.2 Roche Business Overview
7.5.3 Roche Nonalcoholic Steatohepatitis (NASH) Major Product Offerings
7.5.4 Roche Nonalcoholic Steatohepatitis (NASH) Revenue in Global (2016-2021)
7.5.5 Roche Key News
7.6 Vivus
7.6.1 Vivus Corporate Summary
7.6.2 Vivus Business Overview
7.6.3 Vivus Nonalcoholic Steatohepatitis (NASH) Major Product Offerings
7.6.4 Vivus Nonalcoholic Steatohepatitis (NASH) Revenue in Global (2016-2021)
7.6.5 Vivus Key News
7.7 Arisaph Pharmaceuticals
7.7.1 Arisaph Pharmaceuticals Corporate Summary
7.7.2 Arisaph Pharmaceuticals Business Overview
7.7.3 Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Major Product Offerings
7.4.4 Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue in Global (2016-2021)
7.7.5 Arisaph Pharmaceuticals Key News
7.8 Cempra Pharmaceuticals
7.8.1 Cempra Pharmaceuticals Corporate Summary
7.8.2 Cempra Pharmaceuticals Business Overview
7.8.3 Cempra Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Major Product Offerings
7.8.4 Cempra Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue in Global (2016-2021)
7.8.5 Cempra Pharmaceuticals Key News
7.9 Galectin Therapeutics
7.9.1 Galectin Therapeutics Corporate Summary
7.9.2 Galectin Therapeutics Business Overview
7.9.3 Galectin Therapeutics Nonalcoholic Steatohepatitis (NASH) Major Product Offerings
7.9.4 Galectin Therapeutics Nonalcoholic Steatohepatitis (NASH) Revenue in Global (2016-2021)
7.9.5 Galectin Therapeutics Key News
7.10 Galmed Pharmaceuticals
7.10.1 Galmed Pharmaceuticals Corporate Summary
7.10.2 Galmed Pharmaceuticals Business Overview
7.10.3 Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Major Product Offerings
7.10.4 Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue in Global (2016-2021)
7.10.5 Galmed Pharmaceuticals Key News
7.11 Genfit
7.11.1 Genfit Corporate Summary
7.11.2 Genfit Business Overview
7.11.3 Genfit Nonalcoholic Steatohepatitis (NASH) Major Product Offerings
7.11.4 Genfit Nonalcoholic Steatohepatitis (NASH) Revenue in Global (2016-2021)
7.11.5 Genfit Key News
7.12 Gilead
7.12.1 Gilead Corporate Summary
7.12.2 Gilead Business Overview
7.12.3 Gilead Nonalcoholic Steatohepatitis (NASH) Major Product Offerings
7.12.4 Gilead Nonalcoholic Steatohepatitis (NASH) Revenue in Global (2016-2021)
7.12.5 Gilead Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Nonalcoholic Steatohepatitis (NASH) Market Opportunities & Trends in Global Market
Table 2. Nonalcoholic Steatohepatitis (NASH) Market Drivers in Global Market
Table 3. Nonalcoholic Steatohepatitis (NASH) Market Restraints in Global Market
Table 4. Key Players of Nonalcoholic Steatohepatitis (NASH) in Global Market
Table 5. Top Nonalcoholic Steatohepatitis (NASH) Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Nonalcoholic Steatohepatitis (NASH) Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Nonalcoholic Steatohepatitis (NASH) Revenue Share by Companies, 2016-2021
Table 8. Global Companies Nonalcoholic Steatohepatitis (NASH) Product Type
Table 9. List of Global Tier 1 Nonalcoholic Steatohepatitis (NASH) Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Nonalcoholic Steatohepatitis (NASH) Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Nonalcoholic Steatohepatitis (NASH) Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Nonalcoholic Steatohepatitis (NASH) Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Nonalcoholic Steatohepatitis (NASH) Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application - Global Nonalcoholic Steatohepatitis (NASH) Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Nonalcoholic Steatohepatitis (NASH) Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Nonalcoholic Steatohepatitis (NASH) Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region - Global Nonalcoholic Steatohepatitis (NASH) Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Nonalcoholic Steatohepatitis (NASH) Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Nonalcoholic Steatohepatitis (NASH) Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Nonalcoholic Steatohepatitis (NASH) Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Nonalcoholic Steatohepatitis (NASH) Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Nonalcoholic Steatohepatitis (NASH) Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Nonalcoholic Steatohepatitis (NASH) Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Nonalcoholic Steatohepatitis (NASH) Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Nonalcoholic Steatohepatitis (NASH) Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Nonalcoholic Steatohepatitis (NASH) Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Nonalcoholic Steatohepatitis (NASH) Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Revenue, (US$, Mn), 2022-2027
Table 30. AstraZeneca Corporate Summary
Table 31. AstraZeneca Nonalcoholic Steatohepatitis (NASH) Product Offerings
Table 32. AstraZeneca Nonalcoholic Steatohepatitis (NASH) Revenue (US$, Mn), (2016-2021)
Table 33. Arena Pharmaceuticals Corporate Summary
Table 34. Arena Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Product Offerings
Table 35. Arena Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue (US$, Mn), (2016-2021)
Table 36. GSK Corporate Summary
Table 37. GSK Nonalcoholic Steatohepatitis (NASH) Product Offerings
Table 38. GSK Nonalcoholic Steatohepatitis (NASH) Revenue (US$, Mn), (2016-2021)
Table 39. Novo Nordisk Corporate Summary
Table 40. Novo Nordisk Nonalcoholic Steatohepatitis (NASH) Product Offerings
Table 41. Novo Nordisk Nonalcoholic Steatohepatitis (NASH) Revenue (US$, Mn), (2016-2021)
Table 42. Roche Corporate Summary
Table 43. Roche Nonalcoholic Steatohepatitis (NASH) Product Offerings
Table 44. Roche Nonalcoholic Steatohepatitis (NASH) Revenue (US$, Mn), (2016-2021)
Table 45. Vivus Corporate Summary
Table 46. Vivus Nonalcoholic Steatohepatitis (NASH) Product Offerings
Table 47. Vivus Nonalcoholic Steatohepatitis (NASH) Revenue (US$, Mn), (2016-2021)
Table 48. Arisaph Pharmaceuticals Corporate Summary
Table 49. Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Product Offerings
Table 50. Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue (US$, Mn), (2016-2021)
Table 51. Cempra Pharmaceuticals Corporate Summary
Table 52. Cempra Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Product Offerings
Table 53. Cempra Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue (US$, Mn), (2016-2021)
Table 54. Galectin Therapeutics Corporate Summary
Table 55. Galectin Therapeutics Nonalcoholic Steatohepatitis (NASH) Product Offerings
Table 56. Galectin Therapeutics Nonalcoholic Steatohepatitis (NASH) Revenue (US$, Mn), (2016-2021)
Table 57. Galmed Pharmaceuticals Corporate Summary
Table 58. Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Product Offerings
Table 59. Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue (US$, Mn), (2016-2021)
Table 60. Genfit Corporate Summary
Table 61. Genfit Nonalcoholic Steatohepatitis (NASH) Product Offerings
Table 62. Genfit Nonalcoholic Steatohepatitis (NASH) Revenue (US$, Mn), (2016-2021)
Table 63. Gilead Corporate Summary
Table 64. Gilead Nonalcoholic Steatohepatitis (NASH) Product Offerings
Table 65. Gilead Nonalcoholic Steatohepatitis (NASH) Revenue (US$, Mn), (2016-2021)
List of Figures
Figure 1. Nonalcoholic Steatohepatitis (NASH) Segment by Type
Figure 2. Nonalcoholic Steatohepatitis (NASH) Segment by Application
Figure 3. Global Nonalcoholic Steatohepatitis (NASH) Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Nonalcoholic Steatohepatitis (NASH) Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Nonalcoholic Steatohepatitis (NASH) Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Nonalcoholic Steatohepatitis (NASH) Revenue in 2020
Figure 8. By Type - Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share, 2016-2027
Figure 9. By Application - Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share, 2016-2027
Figure 10. By Region - Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share, 2016-2027
Figure 11. By Country - North America Nonalcoholic Steatohepatitis (NASH) Revenue Market Share, 2016-2027
Figure 12. US Nonalcoholic Steatohepatitis (NASH) Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Nonalcoholic Steatohepatitis (NASH) Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Nonalcoholic Steatohepatitis (NASH) Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Nonalcoholic Steatohepatitis (NASH) Revenue Market Share, 2016-2027
Figure 16. Germany Nonalcoholic Steatohepatitis (NASH) Revenue, (US$, Mn), 2016-2027
Figure 17. France Nonalcoholic Steatohepatitis (NASH) Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Nonalcoholic Steatohepatitis (NASH) Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Nonalcoholic Steatohepatitis (NASH) Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Nonalcoholic Steatohepatitis (NASH) Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Nonalcoholic Steatohepatitis (NASH) Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Nonalcoholic Steatohepatitis (NASH) Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Nonalcoholic Steatohepatitis (NASH) Revenue Market Share, 2016-2027
Figure 24. China Nonalcoholic Steatohepatitis (NASH) Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Nonalcoholic Steatohepatitis (NASH) Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Nonalcoholic Steatohepatitis (NASH) Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Nonalcoholic Steatohepatitis (NASH) Revenue, (US$, Mn), 2016-2027
Figure 28. India Nonalcoholic Steatohepatitis (NASH) Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Nonalcoholic Steatohepatitis (NASH) Revenue Market Share, 2016-2027
Figure 30. Brazil Nonalcoholic Steatohepatitis (NASH) Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Nonalcoholic Steatohepatitis (NASH) Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Revenue Market Share, 2016-2027
Figure 33. Turkey Nonalcoholic Steatohepatitis (NASH) Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Nonalcoholic Steatohepatitis (NASH) Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Nonalcoholic Steatohepatitis (NASH) Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Nonalcoholic Steatohepatitis (NASH) Revenue, (US$, Mn), 2016-2027
Figure 37. AstraZeneca Nonalcoholic Steatohepatitis (NASH) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Arena Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. GSK Nonalcoholic Steatohepatitis (NASH) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Novo Nordisk Nonalcoholic Steatohepatitis (NASH) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Roche Nonalcoholic Steatohepatitis (NASH) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Vivus Nonalcoholic Steatohepatitis (NASH) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Cempra Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Galectin Therapeutics Nonalcoholic Steatohepatitis (NASH) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Genfit Nonalcoholic Steatohepatitis (NASH) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. Gilead Nonalcoholic Steatohepatitis (NASH) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

AstraZeneca
Arena Pharmaceuticals
GSK
Novo Nordisk
Roche
Vivus
Arisaph Pharmaceuticals
Cempra Pharmaceuticals
Galectin Therapeutics
Galmed Pharmaceuticals
Genfit
Gilead

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE